Your browser doesn't support javascript.
loading
Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.
Edwards V, David K; Sweeney, David Tyler; Ho, Hibery; Eide, Christopher A; Rofelty, Angela; Agarwal, Anupriya; Liu, Selina Qiuying; Danilov, Alexey V; Lee, Patrice; Chantry, David; McWeeney, Shannon K; Druker, Brian J; Tyner, Jeffrey W; Spurgeon, Stephen E; Loriaux, Marc M.
Afiliação
  • Edwards V DK; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
  • Sweeney DT; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Ho H; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Eide CA; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Rofelty A; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Agarwal A; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Liu SQ; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Danilov AV; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Lee P; Array BioPharma, Boulder, CO, USA.
  • Chantry D; Array BioPharma, Boulder, CO, USA.
  • McWeeney SK; Department of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, USA.
  • Druker BJ; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Tyner JW; Howard Hughes Medical Institute, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.
  • Spurgeon SE; Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, OR, USA.
  • Loriaux MM; Division of Hematology & Medical Oncology, Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
Oncotarget ; 9(37): 24576-24589, 2018 May 15.
Article em En | MEDLINE | ID: mdl-29872489

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2018 Tipo de documento: Article